Home/Filings/4/0000950170-24-004343
4//SEC Filing

Hunt Hazel 4

Accession 0000950170-24-004343

CIK 0001088856other

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 8:06 PM ET

Size

8.4 KB

Accession

0000950170-24-004343

Insider Transaction Report

Form 4
Period: 2024-01-08
Hunt Hazel
Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-01-08$3.02/sh+50,000$151,000123,146 total
  • Tax Payment

    Common Stock

    2024-01-08$27.46/sh29,792$818,08893,354 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-01-0850,0000 total
    Exercise: $3.02Exp: 2024-02-06Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were to expire on February 6, 2024.
  • [F2]Fully exercisable.

Documents

1 file

Issuer

CORCEPT THERAPEUTICS INC

CIK 0001088856

Entity typeother

Related Parties

1
  • filerCIK 0001698307

Filing Metadata

Form type
4
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 8:06 PM ET
Size
8.4 KB